These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19070628)

  • 1. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.
    Wang M; Wang M; Cheng G; Zhang Z; Fu G; Zhang Z
    Mutat Res; 2009 Feb; 661(1-2):85-92. PubMed ID: 19070628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysis.
    Zhang Z; Wang S; Wang M; Tong N; Fu G; Zhang Z
    Carcinogenesis; 2008 Oct; 29(10):1973-8. PubMed ID: 18684727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exon 3 polymorphisms and haplotypes of O6-methylguanine-DNA methyltransferase and risk of bladder cancer in southern China: a case-control analysis.
    Li C; Liu J; Li A; Qian L; Wang X; Wei Q; Zhou J; Zhang Z
    Cancer Lett; 2005 Sep; 227(1):49-57. PubMed ID: 15885889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
    Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
    Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.
    Hu Z; Wang H; Shao M; Jin G; Sun W; Wang Y; Liu H; Wang Y; Ma H; Qian J; Jin L; Wei Q; Lu D; Huang W; Shen H
    Hum Mutat; 2007 May; 28(5):431-40. PubMed ID: 17285603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
    Ahirwar D; Mandhani A; Mittal RD
    Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polymorphism in the APE1 gene promoter is associated with lung cancer risk.
    Lo YL; Jou YS; Hsiao CF; Chang GC; Tsai YH; Su WC; Chen KY; Chen YM; Huang MS; Hu CY; Chen CJ; Hsiung CA
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):223-9. PubMed ID: 19124501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death receptor 4 and bladder cancer risk.
    Hazra A; Chamberlain RM; Grossman HB; Zhu Y; Spitz MR; Wu X
    Cancer Res; 2003 Mar; 63(6):1157-9. PubMed ID: 12649168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
    Yang H; Dinney CP; Ye Y; Zhu Y; Grossman HB; Wu X
    Cancer Res; 2008 Apr; 68(7):2530-7. PubMed ID: 18381463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
    Ye Y; Yang H; Grossman HB; Dinney C; Wu X; Gu J
    Cancer; 2008 Jun; 112(11):2467-74. PubMed ID: 18361427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
    Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
    BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.
    Yang H; Gu J; Lin X; Grossman HB; Ye Y; Dinney CP; Wu X
    Clin Cancer Res; 2008 Apr; 14(7):2236-44. PubMed ID: 18381966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk.
    Chen M; Kamat AM; Huang M; Grossman HB; Dinney CP; Lerner SP; Wu X; Gu J
    Carcinogenesis; 2007 Oct; 28(10):2160-5. PubMed ID: 17728339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the vitamin D receptor gene and risk of lung cancer.
    Dogan I; Onen HI; Yurdakul AS; Konac E; Ozturk C; Varol A; Ekmekci A
    Med Sci Monit; 2009 Aug; 15(8):BR232-42. PubMed ID: 19644412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk.
    Liu B; Zhang Y; Jin M; Ni Q; Liang X; Ma X; Yao K; Li Q; Chen K
    Mol Carcinog; 2010 Jan; 49(1):75-84. PubMed ID: 19795398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.
    Zhu Y; Lai M; Yang H; Lin J; Huang M; Grossman HB; Dinney CP; Wu X
    Carcinogenesis; 2007 Mar; 28(3):698-703. PubMed ID: 17052994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder.
    Sak SC; Barrett JH; Paul AB; Bishop DT; Kiltie AE
    Br J Cancer; 2005 Jun; 92(12):2262-5. PubMed ID: 15886698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case-control study on JWA promoter -76G-->C polymorphism and the susceptibility of bladder cancer].
    Wu W; Li CP; Chen R; Cao XJ; Li AP; Wang Y; Yang KH; Qian LX; Liu QZ; Li ZL; Zhou JW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):648-52. PubMed ID: 16331563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer].
    Liu J; Yang XM; Liu G; Chang LS; Zhang LR; Song DK
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3122-5. PubMed ID: 20193274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk.
    Frank B; Hemminki K; Shanmugam KS; Meindl A; Klaes R; Schmutzler RK; Wappenschmidt B; Untch M; Bugert P; Bartram CR; Burwinkel B
    Carcinogenesis; 2005 Nov; 26(11):1975-7. PubMed ID: 15975957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.